Oncoinvent grants 20,000 share options to new chief medical officer
Bitget2026/10/28 06:03- Oncoinvent granted new Chief Medical Officer Zuzana Jiráková Trnková 20,000 share options on October 28, 2026, under its long-term incentive program.
- Each option carries a NOK 67.35 strike price, entitling the holder to one share upon exercise; the grant requires no payment.
- No options vest during the first 12 months; 13/48 vest in month 13.
- Remaining options vest in monthly installments of 1/48, subject to continued employment.
- Unexercised options expire seven years from the grant date.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Honda Motor (HMC.US) Reports 65.7% Increase in Net Profit in the First Half, Plans to Expand Production Capacity in North America and Brazil
Honda Motor (HMC.US) released its financial results for the first half of fiscal year 2027 on November 10.
Crypto winter not over? Mining rig hosting provider Bitari cancels orders at the last minute, IPO plans put on hold
Bitcoin mining service provider Bitari has withdrawn its Nasdaq IPO plan. The company originally intended to issue 4.3 million shares at $7 per share to raise $30 million. Its annual revenue is approximately $11 million.
Pre-orders for GTA 6 are booming and may reverse the downward trend! Citigroup raises Take-Two Interactive Software (TTWO.US) target to $270
Citigroup maintains a "Buy" rating on Take-Two Interactive Software, with a target price of $270.
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Crypto prices
More
